Published • loading... • Updated
Evonik invests US$100 million to upgrade its U.S. drug substance contract manufacturing site
Summary by News Medical
2 Articles
2 Articles
News MedicalReposted by 
Pharma Excipients
Pharma ExcipientsEvonik invests US$100 million to upgrade its U.S. drug substance contract manufacturing site
Evonik is making a significant investment to strengthen manufacturing capabilities at its Lafayette (Tippecanoe), Indiana facility.
·Mona Vale, Australia
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
